SeSaM-Biotech provides companies and institutes with novel enzymes for research or biocatalysis in industrial or medical processes.
Watch a short introduction of SeSaM-Biotech given by our CEO, David Schönauer.
Our platform technology Sequence Saturation Mutagenesis (SeSaM) is an innovative, unmatched and patented method for generating unbiased diversity of proteins to discover new enzyme functionalities or improve given enzyme properties.
Our protein engineering services include mutant gene libraries and enzyme evolution projects to obtain improved properties for research, medicine and industrial production. Additionally, we offer individual compounds for own successful directed evolution experiments.